Clinical trial
Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With…
NCT00066222 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00066222 |
|---|---|
| Title | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
| Official title | A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell Lung Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Cisplatin, Etoposide, Radiation therapy |
| Enrollment | 72 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2012 |
| Completion | Nov 1, 2013 |
| First posted | Aug 7, 2003 |
| Last update posted | Dec 22, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: